Volume 65, Issue 1 supplement

Search all Pharmacological Reports articles

January 2013

Filter by

Volume:

Sort by

Date published:

New to old Old to new

198 articles in this issue

Physical exercise-Milmed fusion for neuroprotection and neurorestoration in an animal model of Parkinsonism
Trevor Archer
Anders Fredriksson
Honorary lecture 30 December 2013 Pages: 3 - 3
Emerging stem cell-based technologies for drug discovery and toxicity testing
Leonora Bużańska
Plenary lectures 30 December 2013 Pages: 4 - 4
The European pharmacology: Twenty years of success
Fillipo Drago
Plenary lectures 30 December 2013 Pages: 4 - 4
AMD — a vision threatening disease: From physiology to pathology, and currently used therapeutic modalities
Jerzy Z. Nowak
Plenary lectures 30 December 2013 Pages: 5 - 5
Cytisine for smoking cessation: Current evidence
Piotr Tutka
Plenary lectures 30 December 2013 Pages: 5 - 6
Carbon monoxide — poison or therapeutic?
Karol Kramkowski
Symposia: Pharmacology of vascular endothelium 30 December 2013 Pages: 7 - 7
Nitric oxide in cardiovascular system: What’s new after three decades of research?
Rafał Olszanecki
Symposia: Pharmacology of vascular endothelium 30 December 2013 Pages: 7 - 8
Hydrogen sulfide in the circulatory system and its pharmacotherapeutic potential
Marcin Ufnal
Symposia: Pharmacology of vascular endothelium 30 December 2013 Pages: 8 - 8
Mitoprotection is neuroprotection — Novel targets and therapeutics
Carsten Culmsee
Pathophysiology of Neurodegenerative disorders and new treatment perspectives 30 December 2013 Pages: 9 - 9
Nucleolar activity in neurodegenerative diseases
Grzegorz Kreiner
Rosanna Parlato
Pathophysiology of Neurodegenerative disorders and new treatment perspectives 30 December 2013 Pages: 10 - 10
Functional and molecular compensation of the of dopaminergic nigrostriatal system degeneration in relation to early Parkinson’s disease
Katarzyna Kuter
Urszula Głowacka
Norbert A. Dencher
Pathophysiology of Neurodegenerative disorders and new treatment perspectives 30 December 2013 Pages: 10 - 11
Is it possible to treat Parkinson Disease with iPS cells? Pros and Cons
Marcin Majka
Maciej Sułkowski
Pathophysiology of Neurodegenerative disorders and new treatment perspectives 30 December 2013 Pages: 11 - 11
Research and application of medicinal plants in phytotherapy
Kazimierz Głowniak
Jarogniew Łuszczki
Krystyna Skalicka-Woźniak
Phytotherapy 30 December 2013 Pages: 12 - 12
Horse chestnut saponins as a source of new materials for exploratory medicinal chemistry
Grzegorz Grynkiewicz
Katarzyna Koziak
Katarzyna Filip
Phytotherapy 30 December 2013 Pages: 12 - 13
Effects of standardized extracts from Epilobium sp. herbs on of hormone-dependent prostate cancer cells (LNCaP)-searching for active compounds
Anna Kiss
Magdalena Stolarczyk
Sebastian Granica
Phytotherapy 30 December 2013 Pages: 13 - 13
A pharmacological appraisal of medicinal plants with antialcoholic potential — possible molecular mechanisms
Przemysław Ł. Mikołajczak
Phytotherapy 30 December 2013 Pages: 14 - 14
Impact of phytotherapeutic agents on drug metabolism and distribution
Przemysław M. Mrozikiewicz
Phytotherapy 30 December 2013 Pages: 14 - 15
Induced production of secondary metabolites in medicinal plants for pharmacotherapy
Ryszard Słomski
Marlena Szalata
Karolina Wielgus
Phytotherapy 30 December 2013 Pages: 15 - 15
Herbal drugs in atherosclerosis prevention — the new evidence
Hanna Winiarska
Phytotherapy 30 December 2013 Pages: 15 - 16
Can epilepsy be successfully cured?
Barbara Błaszczyk
Progress in epilepsy and antiepileptic drugs 30 December 2013 Pages: 17 - 17
Antiarrhythmic drugs and epilepsy
Kinga Borowicz
Progress in epilepsy and antiepileptic drugs 30 December 2013 Pages: 17 - 18
Current challenges in the treatment of epilepsy
Stanisław J. Czuczwar
Progress in epilepsy and antiepileptic drugs 30 December 2013 Pages: 18 - 18
How early exposure to benzodiazepines affects brain development?
Hana Kubova
Pavel Mareš
Anna Mikulecka
Progress in epilepsy and antiepileptic drugs 30 December 2013 Pages: 19 - 19
Molecular mechanisms of acquired epileptogenesis
Katarzyna Łukasiuk
Progress in epilepsy and antiepileptic drugs 30 December 2013 Pages: 19 - 20
GABA_B receptors and epileptic seizures during postnatal development
Pavel Mareš
Progress in epilepsy and antiepileptic drugs 30 December 2013 Pages: 20 - 20
Positive allosteric modulators at GABA_B receptors as ligands of future to treat depression
Małgorzata Frankowska
Małgorzata Filip
Functional impact of positive allosteric modulators (pams) of metabotropic glutamatergic and gaba receptors in regulation of brain and pain disorders 30 December 2013 Pages: 21 - 21
Metabotropic glutamate receptor type 4, a potential target for chronic pain management
Cyril Goudet
Functional impact of positive allosteric modulators (pams) of metabotropic glutamatergic and gaba receptors in regulation of brain and pain disorders 30 December 2013 Pages: 22 - 22
On the mechanism of antidepressant-like activity of mGlu5 allosteric modulators
Andrzej Pilc
Agnieszka Pałucha-Poniewiera
Gabriel Nowak
Functional impact of positive allosteric modulators (pams) of metabotropic glutamatergic and gaba receptors in regulation of brain and pain disorders 30 December 2013 Pages: 22 - 23
Metabotropic glutamate receptors PAMs as a novel, potential antipsychotic drugs
Joanna M. Wierońska
Anna Sławińska
Andrzej Pilc
Functional impact of positive allosteric modulators (pams) of metabotropic glutamatergic and gaba receptors in regulation of brain and pain disorders 30 December 2013 Pages: 23 - 23
Vital dyes in vitroretinal surgery
Tomasz Chorągiewicz
Robert Rejdak
Sebastian Thaler
Pharmacological strategies against neurodegeneration of the retina and visual pathway 30 December 2013 Pages: 24 - 24
Chronic degeneration in glaucomatous optic neuropathy and neuroprotective strategies in glaucoma
Paweł Grieb
Pharmacological strategies against neurodegeneration of the retina and visual pathway 30 December 2013 Pages: 24 - 25
Novel strategies in pharmacotherapy of demyelinization-related clinically isolated syndromes
Konrad Rejdak
Pharmacological strategies against neurodegeneration of the retina and visual pathway 30 December 2013 Pages: 25 - 25
New drug VEGF Trap-Eye — Eylea in the treatment of age-related macular degeneration, and macular edema in central retinal vein occlusion and diabetic retinopathy
Robert Rejdak
Pharmacological strategies against neurodegeneration of the retina and visual pathway 30 December 2013 Pages: 26 - 26
Tempol — an ocular neuroprotectant?
Sebastian Thaler
Pharmacological strategies against neurodegeneration of the retina and visual pathway 30 December 2013 Pages: 26 - 27
Ketone therapy in central nervous system disorders
Tomasz Żarnowski
Pharmacological strategies against neurodegeneration of the retina and visual pathway 30 December 2013 Pages: 27 - 27
Effect of gabapentin and topiramate on lipopolysaccharide (LPS)-induced proinflammatory cytokine release from primary rat microglial cell cultures
Dariusz Andrzejczak
Agata Woldan-Tambor
Jolanta B. Zawilska
Posters 30 December 2013 Pages: 28 - 28
Antinociceptive effect of the new cyclic dermorphin/deltorphin tetrapeptide analogue in animal models of pain
Bożena Antkowiak
Marek Kowalczyk
Janusz Kocik
Posters 30 December 2013 Pages: 28 - 29
Tumor necrosis factor regulates the gene for brain-derived neurotrophic factor (BDNF) in rat trigeminal ganglion neurons
Ewa Bałkowiec-Iskra
Olga Kuzawińska
Agnieszka Bałkowiec
Posters 30 December 2013 Pages: 29 - 29
The effect of propafenone on the anticonvulsant action of carbamazepine and valproate in the mouse model of maximal electroshock
Monika Banach
Barbara Piskorska
Kinga Borowicz
Posters 30 December 2013 Pages: 30 - 30
Antiproliferative effects of some new oleanolic acid derivatives
Marta Bąkowska
Emilia Kania
Lucjusz Zaprutko
Posters 30 December 2013 Pages: 30 - 31
Validation of selected models of hypertension in rats
Marek Bednarski
Katarzyna Raźny
Joanna Knutelska
Posters 30 December 2013 Pages: 31 - 31
The effect of derivatives of coumarin on genes expression connected with phenomenon of mutlidrug resistance
Anna Bogucka-Kocka
Maria Cioch
Janusz Kocki
Posters 30 December 2013 Pages: 32 - 32
Anxiolytic action of imperatorin from Angelica officinalis
Barbara Budzyńska
Marta Kruk-Słomka
Kazimierz Głowniak
Posters 30 December 2013 Pages: 32 - 33
Metabolism of angiotensin-(1-12) in adipose tissue — ex vivo study in rat model of hypertension
Beata Bujak-Giżycka
Józef Madej
Ryszard Korbut
Posters 30 December 2013 Pages: 33 - 33
Health Technology Assessment as a tool supporting decision making process within the area of reimbursement of medicinal products in Poland
Agnieszka Burda
Ewa Bałkowiec-Iskra
Posters 30 December 2013 Pages: 34 - 34
Ceramide and sphingomyelin levels are changed in prefrontal cortex and hippocampus of rats on high-fat diet
Halina Car
Anna Fiedorowicz
Małgorzata Żendzian-Piotrowska
Posters 30 December 2013 Pages: 34 - 35
Mechanisms of morphine-venlafaxine interaction in diabetic neuropathic pain model
Krystyna Cegielska-Perun
Agata Siwek
Helena Makulska-Nowak
Posters 30 December 2013 Pages: 35 - 35
Action of orally administered macrolides — erythromycin and roxithromycin – on B16 melanoma-transplanted mice
Ewa Chlebda-Sieragowska
Anna Merwid-Ląd
Adam Szeląg
Posters 30 December 2013 Pages: 36 - 36
Increase of hippocampal kynurenic acid level in experimental rat model of diabetes mellitus type 1
Iwona Chmiel-Perzyńska
Adam Perzyński
Ewa M. Urbańska
Posters 30 December 2013 Pages: 36 - 37
Influence of carbenoxolone (an inhibitor of gap junctions) on the protective activity of some antiepileptic drugs in the pentylenetetrazol seizure model in mice
Magdalena Chrościńska-Krawczyk
Barbara Miziak
Stanisław J. Czuczwar
Posters 30 December 2013 Pages: 37 - 37

Volume 65, Issue 1 supplement

Search

Navigation